Clarivate's Epidemiology Intelligence: Precision Population Analysis

By Author: Ben Gross
Total Articles: 444
Comment this article

Clarivate Plc, a global leader in providing transformative intelligence, has just announced the launch of Epidemiology Intelligence™. This innovative solution combines valuable insights from epidemiology, incidence, and prevalence databases, offering a comprehensive understanding of the market. With the inclusion of U.S. claims-based population insights, biopharma companies can now accurately assess market size and target patient demographics effortlessly.

In today's ever-changing market, accurate forecasting is crucial for biopharmaceutical companies. However, traditional research methods often have limitations that can result in inaccurate estimations and costly outcomes. Epidemiology Intelligence provides users with unique insights to address critical questions about the population that can benefit from specific drugs. This solution enables precise assessments, identification of niche populations, and accurate predictions based on population insights.

Ravindra Sharma, VP Product Management at Clarivate, expressed his excitement about the launch of Epidemiology Intelligence, stating that it is a significant ...
... milestone for the company's commitment to delivering comprehensive and actionable solutions to life sciences and healthcare companies. Clients now have access to a unified platform that seamlessly integrates disease epidemiology coverage with expert analysis. This empowers them to develop safe, effective, and commercially successful treatments for patients at a faster pace.

Epidemiology Intelligence greatly enhances data-driven decision-making throughout the drug development lifecycle. Clients can now benchmark market forecasts, validate investments, identify growth opportunities, and strategically position their products for success using this powerful solution.

More Information : https://www.techdogs.com/tech-news/pr-newswire/clarivate-introduces-epidemiology-intelligence-for-precision-patient-population-analysis